Tripatide (Yunnan First Applied Pharma)

特立帕肽(云南先施药业)

Report date: 2025/12/29 09:31:04

Base Information

Drug NameTripatide (Yunnan First Applied Pharma)
Drug Alias Name特立帕肽(2.2类改良型)
ClassificationSmall molecules > Synthetic peptide
Mechanisms of ActionParathyroid hormone replacements
TargetsParathyroid hormone receptor
Therapy Area/IndicationsOsteoporosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsOsteoporosis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A